Table 3 Response after treatment in Group A (n = 35)
From: Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
CR (%) | PR (%) | SD (%) | PD (%) | |
|---|---|---|---|---|
Primary cervical mass | 29 (83) | 5 (14) | 1 (3) | 0 (0) |
Metastatic LNa) | 22 (63) | 12 (34) | 0 (0) | 1 (3) |
Overallb) | 21 (60) | 12 (34) | 1 (3) | 1 (3) |